TherapeuticsMD (TXMD) Amortization - Intangibles (2024 - 2026)

TherapeuticsMD (TXMD) has reported Amortization - Intangibles for 3 consecutive years, with $13000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Amortization - Intangibles fell 86.46% year-over-year to $13000.0; the trailing twelve-month figure through Jun 2026 stood at $195000.0 (down 82.88% YoY), and the FY2025 full-year result was $176000.0, down 86.12% from the prior year.
• Amortization - Intangibles slipped to $13000.0 in Q2 2026 per TXMD's latest filing, from $94000.0 in the prior quarter.
• Across five years, Amortization - Intangibles topped out at $859000.0 in Q4 2024 and bottomed at $13000.0 in Q2 2026.
• Historically, Amortization - Intangibles has averaged $165700.0 across 3 years, with a median of $95000.0 in 2024.
• The sharpest annual moves came in 2025 and 2026: Amortization - Intangibles slumped 93.48% in 2025, then climbed 6.82% in 2026.
• Over 3 years, Amortization - Intangibles stood at $859000.0 in 2024, then plunged by 93.48% to $56000.0 in 2025, then slumped by 76.79% to $13000.0 in 2026.
• According to Business Quant data, Amortization - Intangibles over the past three periods registered $13000.0, $94000.0, and $56000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.